Bertilimumab Emerging Drug Insight and Market Forecasts, 2019-2032: A Fully Human Monoclonal Antibody with Specificity for Human Eotaxin-1 and Inhibits its Function

Posted on by

DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Bertilimumab Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about bertilimumab for bullous pemphigoid in the seven major markets. A detailed…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.